A Personalized Protocol If peptides make sense for your situation, your provider builds a protocol around your goals, choosing specific peptides, dosing, and timing
Among GLP-1RAs with notable neuroprotective potential, NLY01, a PEGylated form of exendin-4, has emerged as a long-acting agent
Biochemistry 2007;46:15089-102
Our structures of Cagri-AMYR-G s complexes allow direct examination of the influence of a C-terminal proline in an amylin-template peptide through comparison of the interactions formed by P37 Cagri to that of Y37 rAmy with the CTR and AMYRs
Ajanta Pharma has entered the fast-growing GLP-1 space through a strategic in-licensing deal with Biocon for semaglutide to exclusively market in 23 countries across Africa, Middle East, Central Asia